Potential drug for Alzheimer’s disease could block early damage, MCG researcher says

Most drugs proposed for Alzheimer’s disease target the gunk that accumulates in the brains of patients but fail to take enough away to make a difference or improve outcomes, said the head of the new Alzheimer’s Therapeutics Discovery program at Medical College of Georgia. It would be better to target a mechanism much earlier in the process, and there appears to be a drug already tested in humans that might do that, Dr. Qin Wang said.

Read the full article here